Peanut Allergy - No Longer a Life Sentence

Kok Wee Chong; Paul J Turner

doi:10.5644/ama2006-124.298

Peanut Allergy - No Longer a Life Sentence

Acta Med Acad. 2020 Aug;49(2):198-206. doi: 10.5644/ama2006-124.298.

Authors

Kok Wee Chong¹, Paul J Turner²

Affiliations

¹ Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK; Allergy Service, Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore. chong.kok.wee@singhealth.com.sg.
² Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK; Discipline of Paediatrics and Child Health, School of Medicine, University of Sydney, Sydney, New South Wales, Australia.

PMID: 33189125
DOI: 10.5644/ama2006-124.298

Abstract

In this review we provide an overview on the latest knowledge in the prevention and active management of peanut allergy. The rise in incidence of food allergy has generated new challenges in the management of affected individuals. Strategies to counteract the increase in prevalence of peanut allergy can be considered as a pyramid, beginning with primary prevention of those at risk through earlier introduction of peanut into the infant diet, to secondary prevention of peanut-sensitised children through improvements in the correct diagnosis of peanut allergy and finally to the treatment of children with proven peanut allergy. CONCLUSION: With the paradigm shift towards an active management, peanut allergy should no longer be seen as a life sentence.

Keywords: Immunotherapy; Peanut Allergy; Prevention.

Publication types

Review

MeSH terms

Desensitization, Immunologic / methods*
Diet
Humans
Immunoglobulin E / blood
Peanut Hypersensitivity / diagnosis
Peanut Hypersensitivity / drug therapy
Peanut Hypersensitivity / epidemiology
Peanut Hypersensitivity / prevention & control*
Primary Prevention
Secondary Prevention
Skin Tests

Substances

Immunoglobulin E